Holen Sie sich die Stockscreener-App
3.525
7.32%
0.245
Schlusskurs vom Vortag:
$3.28
Offen:
$3.31
24-Stunden-Volumen:
904.02K
Relative Volume:
0.91
Marktkapitalisierung:
$486.75M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-45.44M
KGV:
-10.07
EPS:
-0.35
Netto-Cashflow:
$-42.28M
1W Leistung:
+25.71%
1M Leistung:
+10.00%
6M Leistung:
+21.38%
1J Leistung:
+195.80%
1-Tages-Spanne:
$3.29
$3.615
1-Wochen-Bereich:
$2.79
$3.615
52-Wochen-Spanne:
$1.25
$4.08
Compass Therapeutics Inc Stock (CMPX) Company Profile
Firmenname
Compass Therapeutics Inc
Sektor
Branche
Telefon
617-500-8099
Adresse
80 GUEST STREET, BOSTON
Vergleichen Sie CMPX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CMPX
Compass Therapeutics Inc
|
3.52 | 435.59M | 0 | -45.44M | -42.28M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.95 | 99.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
579.05 | 62.21B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.01 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
701.75 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.46 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-01 | Fortgesetzt | Raymond James | Outperform |
| 2025-04-02 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-24 | Eingeleitet | Guggenheim | Buy |
| 2025-02-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-12-23 | Eingeleitet | D. Boral Capital | Buy |
| 2024-11-15 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-09-16 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2023-01-31 | Eingeleitet | Jefferies | Buy |
| 2023-01-27 | Eingeleitet | Stifel | Buy |
| 2022-05-23 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-03-15 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-01-19 | Eingeleitet | B. Riley Securities | Buy |
| 2021-12-22 | Eingeleitet | Raymond James | Outperform |
| 2021-12-20 | Eingeleitet | SVB Leerink | Outperform |
| 2021-12-15 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Compass Therapeutics Inc Aktie (CMPX) Neueste Nachrichten
Will earnings trigger a reversal in Compass Therapeutics Inc.Profit Target & Technical Pattern Based Signals - Newser
Custom strategy builders for tracking Compass Therapeutics Inc.Weekly Trade Recap & High Conviction Investment Ideas - Newser
Short interest data insights for Compass Therapeutics Inc.Earnings Overview Summary & Free High Return Stock Watch Alerts - Newser
Using Bollinger Bands to evaluate Compass Therapeutics Inc.Earnings Trend Report & Technical Buy Zone Confirmation - Newser
Applying sector rotation models to Compass Therapeutics Inc.Portfolio Growth Summary & Weekly Breakout Watchlists - Newser
Will Compass Therapeutics Inc. benefit from macro trendsTrade Analysis Report & Fast Gain Stock Trading Tips - Newser
What MACD and RSI say about Compass Therapeutics Inc.Weekly Gains Summary & Weekly Watchlist for Consistent Profits - Newser
Is Compass Therapeutics Inc. stock bottoming outMarket Risk Report & Smart Allocation Stock Tips - Newser
Visualizing Compass Therapeutics Inc. stock with heatmapsJuly 2025 Selloffs & AI Enhanced Trading Alerts - Newser
Statistical indicators supporting Compass Therapeutics Inc.’s strengthJuly 2025 Reactions & High Conviction Investment Ideas - Newser
What does recent volatility data suggest for Compass Therapeutics Inc.Weekly Earnings Recap & Daily Risk Controlled Trade Plans - Newser
Will Compass Therapeutics Inc. stock go up soonJuly 2025 PostEarnings & Weekly Market Pulse Alerts - Newser
Advanced analytics toolkit walkthrough for Compass Therapeutics Inc.Market Growth Summary & Free Expert Approved Momentum Trade Ideas - Newser
How sentiment analysis helps forecast Compass Therapeutics Inc.July 2025 Trends & Low Risk Growth Stock Ideas - Newser
Can Compass Therapeutics Inc. hit a new high this monthQuarterly Market Review & Real-Time Sentiment Analysis - Newser
Technical analysis overview for Compass Therapeutics Inc. stockStop Loss & Free Weekly Watchlist of Top Performers - Newser
Is Compass Therapeutics Inc. forming a bottoming baseEarnings Miss & Safe Swing Trade Setups - Newser
Will Compass Therapeutics Inc. bounce back from current supportPortfolio Risk Report & Fast Exit and Entry Trade Guides - Newser
BTIG Raises Compass's PT to $11 from $9, Maintains Buy Rating - AInvest
Can volume confirm reversal in Compass Therapeutics Inc.Weekly Trend Summary & Low Risk High Win Rate Stock Picks - Newser
What MACD signals say about Compass Therapeutics Inc.Bond Market & Safe Entry Point Alerts - Newser
Heatmap analysis for Compass Therapeutics Inc. and competitorsWeekly Trade Recap & Precise Trade Entry Recommendations - Newser
Technical signs of recovery in Compass Therapeutics Inc.Trade Entry Summary & Long-Term Safe Return Strategies - Newser
Using portfolio simulators with Compass Therapeutics Inc. includedJuly 2025 Volume & Reliable Price Breakout Alerts - Newser
Compass Therapeutics to Participate in Upcoming September Investor Events - GlobeNewswire
Compass Therapeutics to Participate in Upcoming September Investor Events - GlobeNewswire Inc.
Intraday pattern recognizer results for Compass Therapeutics Inc.Trade Risk Report & Risk Controlled Daily Plans - Newser
How to read the order book for Compass Therapeutics Inc.July 2025 Movers & Accurate Intraday Trading Signals - Newser
Multi asset correlation models including Compass Therapeutics Inc.Portfolio Value Report & Technical Pattern Alert System - Newser
Is Compass Therapeutics Inc. forming a reversal patternJuly 2025 Retail & Free Reliable Trade Execution Plans - Newser
Finanzdaten der Compass Therapeutics Inc-Aktie (CMPX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Compass Therapeutics Inc-Aktie (CMPX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| GORDON CARL L | Director |
Apr 09 '25 |
Sale |
1.59 |
3,571,428 |
5,678,571 |
0 |
| ORBIMED ADVISORS LLC | Director |
Apr 09 '25 |
Sale |
1.59 |
3,571,428 |
5,678,571 |
0 |
1.41%
0.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):